Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Senescence”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT07354269
What this trial is testing

Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations

Who this might be right for
Poliomyelitis
Sinovac Biotech Co., Ltd 180
Early research (Phase 1)Study completedNCT04530656
What this trial is testing

Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 168
Testing effectiveness (Phase 2)Study completedNCT00318149
What this trial is testing

Safety Study of Four Candidate Influenza Vaccines to Prevent Influenza Disease in the Elderly Population

Who this might be right for
Influenza
GlaxoSmithKline 425
Large-scale testing (Phase 3)Study completedNCT02621164
What this trial is testing

Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and Adolescents

Who this might be right for
Influenza, Human
SK Chemicals Co., Ltd. 454
Large-scale testing (Phase 3)Study completedNCT02367664
What this trial is testing

A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants

Who this might be right for
Encephalitis
Jiangsu Province Centers for Disease Control and Prevention 900
Not applicableLooking for participantsNCT06987890
What this trial is testing

Practical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy

Who this might be right for
Lung Cancer (NSCLC)Geriatric AssessmentStereotactic Body Radiation Therapy (SBRT)
Brigham and Women's Hospital 64
Testing effectiveness (Phase 2)Study completedNCT05595915
What this trial is testing

COMP-4 Supplementation and Brachial Artery FMD

Who this might be right for
AgingEndothelial DysfunctionSenescence
University of California, Los Angeles 32
Not applicableStudy completedNCT00068497
What this trial is testing

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

Who this might be right for
Anaplastic Thyroid CancerInsular Thyroid CancerMetastatic Parathyroid Cancer+83 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Ended earlyNCT01013961
What this trial is testing

Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
ECOG-ACRIN Cancer Research Group 31
Large-scale testing (Phase 3)UnknownNCT00209209
What this trial is testing

Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL

Who this might be right for
Lymphoma, Mantle-Cell
European Mantle Cell Lymphoma Network 570
Testing effectiveness (Phase 2)Study completedNCT00396045
What this trial is testing

Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Turin, Italy 54
Large-scale testing (Phase 3)Study completedNCT00169130
What this trial is testing

ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma, Large-Cell, Diffuse
Lymphoma Study Association 300
Not applicableStudy completedNCT05407805
What this trial is testing

Learn About Sickle Cell Disease In Adult Patients

Who this might be right for
Sickle Cell Disease
Pfizer 98
Large-scale testing (Phase 3)Study completedNCT00262795
What this trial is testing

Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 206
Large-scale testing (Phase 3)Study completedNCT00482677
What this trial is testing

Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Canadian Cancer Trials Group 562
Early research (Phase 1)Study completedNCT06101173
What this trial is testing

Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults

Who this might be right for
Poliomyelitis
CanSino Biologics Inc. 72
Large-scale testing (Phase 3)Study completedNCT07357545
What this trial is testing

Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried

Who this might be right for
Rabies (Healthy Volunteers)
Sinovac Biotech Co., Ltd 2,040
Testing effectiveness (Phase 2)UnknownNCT04058470
What this trial is testing

Toripalimab Plus Rituximab Followed by R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaFollicular Lymphoma Grade IIIb+3 more
Huiqiang Huang 140
Not applicableStudy completedNCT05101759
What this trial is testing

Impact of Chemotherapeutic Treatments in Patients Aged 75 Years and Over Treated for Lymphoid Hematological Malignancy

Who this might be right for
Neoplasm, Plasma CellLymphoma
University Hospital, Toulouse 100
Large-scale testing (Phase 3)Looking for participantsNCT04892173
What this trial is testing

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Who this might be right for
Carcinoma, Squamous Cell
Johnson & Johnson Enterprise Innovation Inc. 500
Next Page